NEW YORK (360Dx) – When Owlstone Medical today announced a collaboration with Renji Hospital to conduct a clinical study into the early detection of lung cancer in China, the deal became one among several clinical studies in which the firm is participating to validate its breath biopsy platform.
Although financial and other terms of the deal were not disclosed, the partners said that they will establish a breath biopsy laboratory in China to support the study.